- Home
- NUWE vs TTNP Comparison
NUWE vs TTNP Comparison
Compare NUWE & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- TTNP
- Stock Information
- Founded
- NUWE 1999
- TTNP 1991
- Country
- NUWE United States
- TTNP United States
- Employees
- NUWE N/A
- TTNP N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NUWE Health Care
- TTNP Health Care
- Exchange
- NUWE Nasdaq
- TTNP Nasdaq
- Market Cap
- NUWE 3.9M
- TTNP 3.4M
- IPO Year
- NUWE N/A
- TTNP 1996
- Fundamental
- Price
- NUWE $0.40
- TTNP $4.65
- Analyst Decision
- NUWE Strong Buy
- TTNP
- Analyst Count
- NUWE 1
- TTNP 0
- Target Price
- NUWE $17.00
- TTNP N/A
- AVG Volume (30 Days)
- NUWE 187.8K
- TTNP 81.0K
- Earning Date
- NUWE 05-13-2025
- TTNP 05-14-2025
- Dividend Yield
- NUWE N/A
- TTNP N/A
- EPS Growth
- NUWE N/A
- TTNP N/A
- EPS
- NUWE N/A
- TTNP N/A
- Revenue
- NUWE $8,787,000.00
- TTNP N/A
- Revenue This Year
- NUWE $26.81
- TTNP N/A
- Revenue Next Year
- NUWE $48.74
- TTNP N/A
- P/E Ratio
- NUWE N/A
- TTNP N/A
- Revenue Growth
- NUWE N/A
- TTNP N/A
- 52 Week Low
- NUWE $0.40
- TTNP $3.03
- 52 Week High
- NUWE $8.40
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- NUWE 15.96
- TTNP 53.37
- Support Level
- NUWE $0.76
- TTNP $4.16
- Resistance Level
- NUWE $0.95
- TTNP $5.12
- Average True Range (ATR)
- NUWE 0.09
- TTNP 0.44
- MACD
- NUWE -0.05
- TTNP -0.01
- Stochastic Oscillator
- NUWE 0.00
- TTNP 51.54
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.